Healix

Outpatient Parenteral Antibiotic Therapy (OPAT) with Telavancin: A Multi-Center Experience

Authors:
Robin H. Dretler, MD – Infectious Disease Specialists of Atlanta, Atlanta, GA
John S. Adams, MD – Knoxville Infectious Disease Consultants, PC, Knoxville, TN
Michael P. Dailey, MD – Infectious Disease Services of Georgia, Roswell, GA
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.

FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound